Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.

Vasile VC, Jaffe AS.

Curr Cardiol Rep. 2017 Aug 24;19(10):92. doi: 10.1007/s11886-017-0904-4. Review.

PMID:
28840515
2.

Natriuretic Peptides and Analytical Barriers.

Vasile VC, Jaffe AS.

Clin Chem. 2017 Jan;63(1):50-58. doi: 10.1373/clinchem.2016.254714. Epub 2016 Oct 10. Review.

3.

Does cardiac rhythm monitoring in patients with elevated troponin levels lead to changes in management?

Sharain K, Vasile VC, Jaffe AS.

Eur Heart J Acute Cardiovasc Care. 2017 Sep;6(6):545-552. doi: 10.1177/2048872615627709. Epub 2016 Jan 27.

PMID:
26819344
4.

Emerging biomarkers for acute heart conditions.

Vasile VC, Jaffe AS.

Curr Opin Cardiol. 2014 Jul;29(4):312-8. doi: 10.1097/HCO.0000000000000077. Review.

PMID:
24806784
5.

Elevated cardiac troponin T levels in critically ill patients with sepsis.

Vasile VC, Chai HS, Abdeldayem D, Afessa B, Jaffe AS.

Am J Med. 2013 Dec;126(12):1114-21. doi: 10.1016/j.amjmed.2013.06.029. Epub 2013 Sep 28.

PMID:
24083646
6.

Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T.

Jaffe AS, Vasile VC, Milone M, Saenger AK, Olson KN, Apple FS.

J Am Coll Cardiol. 2011 Oct 18;58(17):1819-24. doi: 10.1016/j.jacc.2011.08.026. Epub 2011 Sep 29.

7.

Biologic variation of a novel cardiac troponin I assay.

Vasile VC, Saenger AK, Kroning JM, Klee GG, Jaffe AS.

Clin Chem. 2011 Jul;57(7):1080-1. doi: 10.1373/clinchem.2011.162545. Epub 2011 Apr 25. No abstract available. Erratum in: Clin Chem. 2012 Mar;58(3):647.

8.

Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease.

Vasile VC, Chai HS, Khambatta S, Afessa B, Jaffe AS.

Am J Med. 2010 Nov;123(11):1049-58. doi: 10.1016/j.amjmed.2010.06.021.

PMID:
21035593
9.

Biological and analytical variability of a novel high-sensitivity cardiac troponin T assay.

Vasile VC, Saenger AK, Kroning JM, Jaffe AS.

Clin Chem. 2010 Jul;56(7):1086-90. doi: 10.1373/clinchem.2009.140616. Epub 2010 May 14.

10.

Aborted myocardial infarction: is it real in the troponin era?

Vasile VC, Babuin L, Ting HH, Bell MR, Orme NM, Yuan BY, Perez JA, Alegria JR, Bellolio F, Haro LH, Jaffe AS.

Am Heart J. 2009 Apr;157(4):636-41. doi: 10.1016/j.ahj.2008.12.005. Epub 2009 Jan 31. Review. Erratum in: Am Heart J. 2009 Jul;158(1):77.

PMID:
19332189
11.

Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding.

Vasile VC, Babuin L, Rio Perez JA, Alegria JR, Song LM, Chai HS, Afessa B, Jaffe AS.

Crit Care Med. 2009 Jan;37(1):140-7. doi: 10.1097/CCM.0b013e318192faa3.

PMID:
19050617
12.

Relationship of MRI-determined infarct size and cTnI measurements in patients with ST-elevation myocardial infarction.

Vasile VC, Babuin L, Giannitsis E, Katus HA, Jaffe AS.

Clin Chem. 2008 Mar;54(3):617-9. doi: 10.1373/clinchem.2007.095604. No abstract available.

13.

Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients.

Babuin L, Vasile VC, Rio Perez JA, Alegria JR, Chai HS, Afessa B, Jaffe AS.

Crit Care Med. 2008 Mar;36(3):759-65. doi: 10.1097/CCM.0B013E318164E2E4.

PMID:
18209672
14.

New potential uses for cardiac troponins.

Vasile VC, Jaffe AS.

Biomark Med. 2007 Dec;1(4):491-501. doi: 10.2217/17520363.1.4.491.

PMID:
20477369
15.

Obstructive hypertrophic cardiomyopathy is associated with reduced expression of vinculin in the intercalated disc.

Vasile VC, Edwards WD, Ommen SR, Ackerman MJ.

Biochem Biophys Res Commun. 2006 Oct 20;349(2):709-15. Epub 2006 Aug 24.

PMID:
16949038
16.

TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway.

Rajamannan NM, Subramaniam M, Abraham TP, Vasile VC, Ackerman MJ, Monroe DG, Chew TL, Spelsberg TC.

J Cell Biochem. 2007 Feb 1;100(2):315-25.

17.

A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy.

Vasile VC, Ommen SR, Edwards WD, Ackerman MJ.

Biochem Biophys Res Commun. 2006 Jul 7;345(3):998-1003. Epub 2006 May 4.

PMID:
16712796
18.

Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy.

Vasile VC, Will ML, Ommen SR, Edwards WD, Olson TM, Ackerman MJ.

Mol Genet Metab. 2006 Feb;87(2):169-74. Epub 2005 Oct 19.

PMID:
16236538
19.

Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, Gersh BJ, Ackerman MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10.

Supplemental Content

Loading ...
Support Center